athenahealth, Inc. (NASDAQ:ATHN)‘s stock had its “buy” rating reiterated by KeyCorp in a research note issued to investors on Sunday. They currently have a $170.00 price objective on the health services provider’s stock. KeyCorp’s price target would suggest a potential upside of 31.84% from the stock’s current price.

ATHN has been the topic of a number of other reports. William Blair reissued a “market perform” rating on shares of athenahealth in a research note on Friday, July 21st. Robert W. Baird reissued a “buy” rating and issued a $170.00 target price on shares of athenahealth in a research note on Thursday, August 31st. Argus initiated coverage on shares of athenahealth in a research note on Friday, July 7th. They issued a “hold” rating on the stock. Citigroup Inc. reissued a “buy” rating and issued a $163.00 target price (up from $128.00) on shares of athenahealth in a research note on Monday, June 5th. Finally, J P Morgan Chase & Co set a $136.00 target price on shares of athenahealth and gave the stock a “hold” rating in a research note on Wednesday, July 19th. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and thirteen have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $149.77.

Shares of athenahealth (NASDAQ ATHN) opened at 128.94 on Friday. The stock has a 50 day moving average price of $139.00 and a 200 day moving average price of $128.87. The company has a market capitalization of $5.15 billion, a PE ratio of 163.63 and a beta of 1.79. athenahealth has a one year low of $90.11 and a one year high of $158.66.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings results on Thursday, July 20th. The health services provider reported $0.51 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.39 by $0.12. athenahealth had a net margin of 2.80% and a return on equity of 6.91%. The firm had revenue of $301.10 million for the quarter, compared to analyst estimates of $298.68 million. During the same period last year, the company posted $0.34 EPS. athenahealth’s quarterly revenue was up 15.0% compared to the same quarter last year. On average, equities research analysts predict that athenahealth will post $1.91 earnings per share for the current year.

WARNING: This article was first published by American Banking News and is the property of of American Banking News. If you are accessing this article on another website, it was illegally copied and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/09/17/keycorp-reaffirms-buy-rating-for-athenahealth-inc-athn.html.

In other news, Director Brandon H. Hull sold 800 shares of the firm’s stock in a transaction that occurred on Monday, July 3rd. The shares were sold at an average price of $140.81, for a total transaction of $112,648.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Jonathan D. Porter sold 300 shares of the firm’s stock in a transaction that occurred on Monday, July 17th. The stock was sold at an average price of $143.13, for a total transaction of $42,939.00. The disclosure for this sale can be found here. Insiders have sold a total of 15,422 shares of company stock valued at $2,182,607 in the last 90 days. Insiders own 3.20% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Turner Investments LLC acquired a new stake in shares of athenahealth during the 2nd quarter worth approximately $105,000. Bessemer Group Inc. increased its holdings in athenahealth by 13.7% in the 2nd quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock valued at $132,000 after purchasing an additional 113 shares during the last quarter. FNY Partners Fund LP increased its holdings in athenahealth by 1,900.0% in the 1st quarter. FNY Partners Fund LP now owns 1,000 shares of the health services provider’s stock valued at $112,000 after purchasing an additional 950 shares during the last quarter. The Manufacturers Life Insurance Company increased its holdings in athenahealth by 7.7% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock valued at $166,000 after purchasing an additional 84 shares during the last quarter. Finally, Seven Bridges Advisors LLC increased its holdings in athenahealth by 5.4% in the 2nd quarter. Seven Bridges Advisors LLC now owns 1,303 shares of the health services provider’s stock valued at $183,000 after purchasing an additional 67 shares during the last quarter.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.